Mekorot Water Company has raised funds through a bond placement
February 2020 — Mekorot Water Company (Mekorot) has completed a fundraising to refinance and develop the company.
Mekorot is a wholly-owned government company under the purview of the Ministry of Energy and Water and the Ministry of Finance. Mekorot was defined in the Water Law as the national water company and it is accountable to the Water Authority – the regulator that supervises Mekorot’s activities on behalf of the state. The company was founded in 1937, before the establishment of the state. Since then, it has made a profound national contribution to realizing the Zionist vision and transforming it into a sustainable reality. The infrastructure and huge water plants founded by Mekorot have essentially facilitated life in Israel and provided solutions, at all times, to all sectors – households, fields, farmers and industrial plants.
Our role in the transaction
Oaklins’ team in Israel advised Mekorot Water Company and acted as a member of the distributors’ consortium.
Talk to the deal team
Related deals
Nexxtlab has successfully raised funding to support its growth
Nexxtlab, a Luxembourg-based energy technology company, has raised growth capital from an experienced international energy player. The investment marks an important milestone in Nexxtlab’s development and will support the company’s commercial expansion across Europe, continued product innovation and the further scaling of its energy management platform.
Learn moreLemvig Biogasanlæg has been acquired by BioticNRG
BioticNRG has acquired Lemvig Biogasanlæg A.M.B.A. in a transaction that expands its presence in the biogas sector and establishes a strategic platform for further growth in the Danish renewable energy market. The acquisition supports the continued development of Lemvig Biogasanlæg while strengthening the production of green gas in Denmark.
Learn moreEmpresa Eléctrica Cochrane has completed a corporate restructuring and liability management process
AES Andes S.A. has completed a corporate restructuring and liability management process that included the acquisition of Toesca’s indirect interest in Empresa Eléctrica Cochrane S.p.A. (Cochrane); the prepayment of Cochrane AES’s 5.50% 2027 international bond; the exchange of Cochrane’s BCOCH-A local bonds for new international bonds issued in Rule 144A/Regulation S format for US$485 million; and the merger between Cochrane and AES Andes.
Learn more